Skip to content

Armata Pharmaceuticals Inc

ARMP

Latest QuantConomy context for ARMP: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
AMEX
Recent signals
3
SEC filings
12
Asset profile

Armata Pharmaceuticals Inc

QuantConomy has a structured record for ARMP. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
ARMP
Name
Armata Pharmaceuticals Inc
Coverage
3 market/data records
Sources
fmp alpaca alphavantage sec nasdaq openfigi
Latest signal rows

Recent signals for ARMP

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
operating income change
very bullish
76
May 13, 12:00 AM ARMP (Q1 2026, operating income): grew 76.0% (-$36.63M → -$8.79M). [sequential period basis, very bullish signal]
net income change
bullish
66
May 13, 12:00 AM ARMP (Q1 2026, net income): grew 33.6% (-$173.80M → -$115.35M). [sequential period basis, bullish signal]
eps change
bullish
67
May 13, 12:00 AM ARMP (Q1 2026, diluted eps): EPS grew 34.2% ($-4.80 → $-3.16). [sequential period basis, bullish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market coverage

Market Exchange Source Asset record
ARMP AMEX fmp Armata Pharmaceuticals, Inc.
ARMP AMEX alpaca Armata Pharmaceuticals, Inc. Common Stock
ARMP NYSE MKT alphavantage Armata Pharmaceuticals Inc

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
12
Date Insider Role Type Shares Price Value Filing
Apr 24, 2026 Gilmer Daniel B. Insider grant 51,280 4 on EDGAR
Mar 14, 2026 Kyme Pierre Chief Business Officer other 1,030 $10.54 $10,856 4 on EDGAR
Mar 14, 2026 Birx Deborah Chief Executive Officer other 4,919 $10.54 $51,846 4 on EDGAR
Mar 9, 2026 PATTI JOSEPH M Insider grant 25,640 4 on EDGAR
Mar 9, 2026 House David Duane SVP, Finance, and PFO grant 109,885 4 on EDGAR
Mar 9, 2026 Peterson Todd C. Insider grant 25,640 4 on EDGAR
Mar 9, 2026 Schlesinger Sarah J. Insider grant 25,640 4 on EDGAR
Mar 9, 2026 Odysseas Kostas D Insider grant 25,640 4 on EDGAR
Mar 9, 2026 Birx Deborah Chief Executive Officer grant 421,226 4 on EDGAR
Mar 9, 2026 Haimovitz Jules Insider grant 25,640 4 on EDGAR
Mar 9, 2026 Kyme Pierre Chief Business Officer grant 183,142 4 on EDGAR
Mar 9, 2026 Kramer Robin Insider grant 25,640 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query ARMP context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access